139 related articles for article (PubMed ID: 16698092)
1. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy.
Navarro J; Aristimuño C; Sánchez-Ramón S; Vigil D; Martínez-Ginés ML; Fernández-Cruz E; de Andrés C
J Neuroimmunol; 2006 Jul; 176(1-2):153-61. PubMed ID: 16698092
[TBL] [Abstract][Full Text] [Related]
2. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.
Ling Y; Cao X; Yu Z; Ruan C
Eur J Haematol; 2007 Oct; 79(4):310-6. PubMed ID: 17692100
[TBL] [Abstract][Full Text] [Related]
3. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse.
Aristimuño C; Navarro J; de Andrés C; Martínez-Ginés L; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
J Neuroimmunol; 2008 Nov; 204(1-2):131-5. PubMed ID: 18835045
[TBL] [Abstract][Full Text] [Related]
4. Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.
de Andrés C; Aristimuño C; Bartolomé M; de Las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
J Neuroimmunol; 2009 Jul; 212(1-2):112-20. PubMed ID: 19446889
[TBL] [Abstract][Full Text] [Related]
5. [Alteration and biological significance of peripheral dendritic cells in patients with chronic idiopathic thrombocytopenic purpura].
Ling Y; Cao XS; Yu ZQ; Qiu GQ; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):187-91. PubMed ID: 18788620
[TBL] [Abstract][Full Text] [Related]
6. Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy.
Krystyna MS; Jacek T; Sebastian R; Ewa B; Halina BP; Zbigniew S; Jacek R
J Neuroimmunol; 2009 Feb; 207(1-2):107-10. PubMed ID: 19162336
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
8. Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation.
Elovaara I; Kuusisto H; Paalavuo R; Särkijärvi S; Lehtimäki T; Huhtala H; Vilpo J
Acta Neurol Scand; 2006 Mar; 113(3):163-6. PubMed ID: 16441245
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity.
Sánchez-Ramón S; Navarro A J; Aristimuño C; Rodríguez-Mahou M; Bellón JM; Fernández-Cruz E; de Andrés C
Immunol Lett; 2005 Jan; 96(2):195-201. PubMed ID: 15585323
[TBL] [Abstract][Full Text] [Related]
10. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
[TBL] [Abstract][Full Text] [Related]
11. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
Mitosek-Szewczyk K; Tabarkiewicz J; Wilczynska B; Lobejko K; Berbecki J; Nastaj M; Dworzanska E; Kolodziejczyk B; Stelmasiak Z; Rolinski J
J Neurol Sci; 2013 Sep; 332(1-2):35-40. PubMed ID: 23835090
[TBL] [Abstract][Full Text] [Related]
12. Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
van der Vliet HJ; Koon HB; Yue SC; Uzunparmak B; Seery V; Gavin MA; Rudensky AY; Atkins MB; Balk SP; Exley MA
Clin Cancer Res; 2007 Apr; 13(7):2100-8. PubMed ID: 17404092
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
[TBL] [Abstract][Full Text] [Related]
17. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance.
Tokita D; Mazariegos GV; Zahorchak AF; Chien N; Abe M; Raimondi G; Thomson AW
Transplantation; 2008 Feb; 85(3):369-77. PubMed ID: 18301333
[TBL] [Abstract][Full Text] [Related]
18. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Sellebjerg F; Hesse D; Limborg S; Lund H; Søndergaard HB; Krakauer M; Sørensen PS
Mult Scler; 2013 Feb; 19(2):179-87. PubMed ID: 22653658
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
